다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

BLRX

BioLineRx (BLRX)

BioLineRx Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BLRX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/06	20:14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2024/04/17	20:00	PR Newswire (US)	BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting	NASDAQ:BLRX	BioLineRx Ltd
2024/03/04	21:47	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2024/02/28	21:08	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2024/02/16	21:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2024/01/08	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BLRX	BioLineRx Ltd
2023/12/30	06:20	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BLRX	BioLineRx Ltd
2023/12/30	06:15	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:BLRX	BioLineRx Ltd
2023/12/21	21:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2023/12/12	21:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2023/11/20	21:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2023/11/20	20:25	IH Market News	Monday’s Wall Street Highlights: GM, Microsoft, Citigroup, Amazon, and more	NASDAQ:BLRX	BioLineRx Ltd
2023/11/01	20:43	PR Newswire (Canada)	BioLineRx a conclu un accord de licence exclusive pour le motixafortide en Asie, sous les conseils de MSQ Ventures	NASDAQ:BLRX	BioLineRx Ltd
2023/10/31	22:00	PR Newswire (US)	BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M.S.Q. Ventures	NASDAQ:BLRX	BioLineRx Ltd
2023/10/31	22:00	PR Newswire (Canada)	BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M.S.Q. Ventures	NASDAQ:BLRX	BioLineRx Ltd
2023/10/27	03:18	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:BLRX	BioLineRx Ltd
2023/10/19	06:07	AllPennyStocks.com	New Collaboration Could Revolutionize Treatment of Chronic Spinal Cord Injuries	NASDAQ:BLRX	BioLineRx Ltd
2023/10/12	20:14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2023/09/28	20:11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2023/09/11	20:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2023/09/11	20:00	PR Newswire (US)	BioLineRx Announces FDA Approval of APHEXDA™ (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Patients with Multiple Myeloma	NASDAQ:BLRX	BioLineRx Ltd
2023/08/30	20:16	IH Market News	Wednesday’s Wall Street Highlights: Ambarella, Alphabet, Toyota, HP Inc, Vinfast, and more	NASDAQ:BLRX	BioLineRx Ltd
2023/08/30	20:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2023/08/30	19:45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2023/08/09	06:25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2023/07/17	20:10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
2023/06/24	05:17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:BLRX	BioLineRx Ltd
2023/05/24	20:07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:BLRX	BioLineRx Ltd
2023/04/25	20:08	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:BLRX	BioLineRx Ltd
2023/04/18	00:09	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:BLRX	BioLineRx Ltd

검색 관련기사 보기:NASDAQ:BLRX

1 2 3 4 5 6 7 8 9 10 다음 >>

Verizon Communications

Health Care Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관